Skip to content

Farmadec: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Farmadec

BE 0896.835.274
NACE 47.730, Retail sale of pharmaceutical products
financial year 31-12-2025 compared with 31-12-2024filed annual accounts (NBB)
Net result for the year
-€32,030
31-12-2024 · €35,985-€68,015
Equity
€163,553
31-12-2024 · €195,583-€32,030
Cash
€31,727
31-12-2024 · €46,033-€14,306
Balance sheet total
€554,731
31-12-2024 · €685,918-€131,187

Largest movements

31-12-2024 to 31-12-2025
Assets
  • Intangible fixed assets -€56,025

    down €56,025 (-14.8%), from €378,232 to €322,207

  • Stocks and contracts -€43,022

    down €43,022 (-41.2%), from €104,316 to €61,293

  • Receivables within one year -€28,732

    down €28,732 (-38.1%), from €75,478 to €46,746

    of which Trade receivables: -€27,605

  • Deferred charges and accrued income +€17,615

    up €17,615 (+223%), from €7,916 to €25,532

  • Cash -€14,306

    down €14,306 (-31.1%), from €46,033 to €31,727

    mainly Debts after one year (-€90,372) and Trade debts (-€49,910)

Equity and liabilities
  • Debts after one year -€90,372

    down €90,372 (-30.3%), from €298,722 to €208,350

  • Trade debts -€49,910

    down €49,910 (-55.3%), from €90,210 to €40,300

  • Other debts +€42,350

    new in 2025: €42,350

  • Profit (loss) carried forward -€32,030

    new in 2025: -€32,030

Income statement
  • Gross operating margin -€83,775

    down €83,775 (-64.6%), from €129,724 to €45,948

  • Taxes -€12,743

    no longer reported in 2025 (was €12,743)

  • Financial charges -€3,495

    down €3,495 (-24.3%), from €14,362 to €10,867

From the 31-12-2024 result to the 31-12-2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 31-12-2024 €35,985
Gross operating margin -€83,775
Depreciation -€54
Other operating charges +€365
Financial income -€788
Financial charges +€3,495
Taxes +€12,743
Result 31-12-2025 -€32,030
raises the resultlowers the result

Derived cash bridge

cash 31-12-2024 to 31-12-2025

Derived from the 31-12-2024 and 31-12-2025 balance sheets and the 31-12-2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€84,474
Investment -€4,583
Financing -€94,196
Cash 31-12-2024 €46,033
Net result for the year -€32,030
Depreciation +€67,325
Stocks and contracts +€43,022
Receivables within one year +€28,732
Deferred charges and accrued income -€17,615
Trade debts -€49,910
Tax, wage and social debts -€243
Other debts +€42,350
Accrued charges and deferred income +€2,842
Investment in fixed assets (net) -€4,583
Debts after one year -€90,372
Current portion of long-term debt -€3,804
Short-term financial debts -€20
Cash 31-12-2025 €31,727
brings cash intakes cash out
Every line side by side 46 lines
Line Code 31-12-2024 31-12-2025 Change %
Total assets 20/58 €685,918 €554,731 -€131,187 -19.1%
Fixed assets 21/28 €452,175 €389,433 -€62,742 -13.9%
Intangible fixed assets 21 €378,232 €322,207 -€56,025 -14.8%
Tangible fixed assets 22/27 €73,943 €67,226 -€6,717 -9.1%
Land and buildings 22 €1,003 €4,991 +€3,988 +398%
Plant, machinery and equipment 23 €23,734 €20,155 -€3,579 -15.1%
Furniture and vehicles 24 €49,206 €42,080 -€7,126 -14.5%
Current assets 29/58 €233,743 €165,298 -€68,445 -29.3%
Stocks and contracts in progress 3 €104,316 €61,293 -€43,022 -41.2%
Stocks 30/36 €104,316 €61,293 -€43,022 -41.2%
Amounts receivable within one year 40/41 €75,478 €46,746 -€28,732 -38.1%
Trade receivables 40 €64,812 €37,207 -€27,605 -42.6%
Other amounts receivable 41 €10,666 €9,539 -€1,127 -10.6%
Cash at bank and in hand 54/58 €46,033 €31,727 -€14,306 -31.1%
Deferred charges and accrued income 490/1 €7,916 €25,532 +€17,615 +223%
Total equity and liabilities 10/49 €685,918 €554,731 -€131,187 -19.1%
Equity 10/15 €195,583 €163,553 -€32,030 -16.4%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €189,383 €189,383 = 0.0%
Distributable reserves 133 €189,383 €189,383 = 0.0%
Profit (loss) carried forward 14 - -€32,030 -€32,030
Amounts payable 17/49 €490,335 €391,178 -€99,157 -20.2%
Amounts payable after more than one year 17 €298,722 €208,350 -€90,372 -30.3%
Financial debts 170/4 €298,722 €208,350 -€90,372 -30.3%
Amounts payable within one year 42/48 €188,855 €177,228 -€11,627 -6.2%
Current portion of amounts payable after more than one year 42 €94,176 €90,372 -€3,804 -4.0%
Financial debts 43 €4,226 €4,206 -€20 -0.5%
Credit institutions 430/8 €4,226 €4,206 -€20 -0.5%
Trade debts 44 €90,210 €40,300 -€49,910 -55.3%
Suppliers 440/4 €90,210 €40,300 -€49,910 -55.3%
Taxes, remuneration and social security 45 €243 - -€243
Taxes 450/3 €243 - -€243
Other amounts payable 47/48 - €42,350 +€42,350
Accrued charges and deferred income 492/3 €2,758 €5,600 +€2,842 +103%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €67,271 €67,325 +€54 +0.1%
Other operating charges 640/8 €968 €602 -€365 -37.7%
Gross operating margin 9900 €129,724 €45,948 -€83,775 -64.6%
Operating profit (loss) 9901 €61,485 -€21,979 -€83,465
Financial income 75/76B €1,604 €816 -€788 -49.1%
Recurring financial income 75 €1,604 €816 -€788 -49.1%
Financial charges 65/66B €14,362 €10,867 -€3,495 -24.3%
Recurring financial charges 65 €14,362 €10,867 -€3,495 -24.3%
Profit (loss) for the period before taxes 9903 €48,728 -€32,030 -€80,758
Income taxes 67/77 €12,743 - -€12,743
Profit (loss) for the period 9904 €35,985 -€32,030 -€68,015
Profit (loss) for the period to be appropriated 9905 €35,985 -€32,030 -€68,015

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.